Type 2 & other diabetes

Longitudinal Analysis of Liver Chemistry Trajectories and Risk of Type 2 Diabetes in Children With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Multicenter Cohort Study

Diabetes CarePublished Multicenter longitudinal cohort study

Authors' conclusion

A 30-unit increase in GGT over time was associated with a substantially higher risk of developing type 2 diabetes in children with MASLD. Together with AST, GGT may provide clinicians with concrete, routinely available parameters to monitor for early risk stratification. Further validation in independent cohorts is needed to confirm these findings and inform clinical application.

Study context

Population
Children with biopsy-confirmed MASLD without T2D at baseline
Participants
1,035 children
Exposure
Longitudinal increases in liver chemistries and T2D risk
Outcome
Incident T2D (fasting glucose, HbA1c, clinical diagnosis)
Follow-up
Mean 3.9 years
Methodological detailsextended Cox models with inverse probability weighting, Liver chemistries measured annually
  • Extended Cox models with inverse probability weighting
  • Liver chemistries measured annually

Main finding

As reported in the abstract

Incident T2D by longitudinal liver chemistry increases (independent models)

Cumulative incidence of T2D

12.3%

Increases in GGT and T2D risk (independent model), HR

1.55 (1.34-1.80) (95% CI)

Increases in AST and T2D risk (independent model), HR

1.31 (1.20-1.43) (95% CI)

Increases in ALT and T2D risk (independent model), HR

1.13 (1.07-1.20) (95% CI)

Observational data: associations, not effects.

Original publication

Longitudinal Analysis of Liver Chemistry Trajectories and Risk of Type 2 Diabetes in Children With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Multicenter Cohort Study. Diabetes Care. Published 9 December 2025. doi:10.2337/dc25-1532

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.